Organisation paid for research Program year 2025 Source: CMS Open Payments

MD Trials, LLC

Neither a doctor nor a teaching hospital

Research payments

$103,003

24 payments

Through program year 2025, MD Trials, LLC is reported as receiving $103,003 in research payments, across 24 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$46,132	12
2021	Research	$1,949	1
2020	Research	$37,922	5
2019	Research	$17,000	6

Breakdown

Who paid Research payments · program years 2019–2025

American Regent $31,691 10 payments
Chugai Pharmaceutical Co., Ltd. $25,550 5 payments
Exeltis, USA Inc. $25,180 2 payments
CSL Behring $20,582 7 payments

Studies the money was for Research payments · program years 2019–2025

Study of DONQ52 in Active Celiac Disease $25,550 5 payments
A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability ofLPRI-424, 13 Cycles $25,180 2 payments
A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis $20,582 7 payments
1Vit17044 $17,000 6 payments
1Vit17044 $14,691 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.